Table 4.
Clinical parameters | No.of cases | CCR2 positive (n =) | Relative expression of PCR products | t | P |
---|---|---|---|---|---|
Age (years) | 0.680 | 0.502 | |||
< 50 | 18 | 10 | 0.5882 ± 0.25209 | ||
> 50 | 28 | 22 | 0.5276 ± 0.22519 | ||
Sex | 1.531 | 0.136 | |||
Male | 27 | 22 | 0.5052 ± 0.20285 | ||
Female | 19 | 10 | 0.6375 ± 0.25610 | ||
Histology | 5.435 | 0.000 | |||
Well, moderate | 32 | 20 | 0.4222 ± 0.18019 | ||
Poor, mucinous | 14 | 12 | 0.7538 ± 0.14160 | ||
Lymph node metastasis | 4.708 | 0.000 | |||
Present | 27 | 21 | 0.6438 ± 0.21555 | ||
Absent | 19 | 11 | 0.3607 ± 0.12423 | ||
Liver metastasis | 1.125 | 0.269 | |||
Present | 12 | 11 | 0.4832 ± 0.20702 | ||
Absent | 34 | 21 | 0.5797 ± 0.24148 | ||
Location | 0.923 | 0.363 | |||
Colon | 28 | 23 | 0.5228 ± 0.22501 | ||
Rectum | 18 | 9 | 0.6071 ± 0.25059 | ||
TNM stage | 3.010 | 0.010 | |||
I + II | 16 | 7 | 0.3673 ± 0.16270 | ||
III + IV | 30 | 25 | 0.5967 ± 0.22504 |